Cellebrite DI Ltd (NAS:CLBTW)
$ 5.2486 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 13.22 GF Score: 53/100

Q3 2024 Cellebrite DI Ltd Earnings Call Transcript

Nov 06, 2024 / 01:30PM GMT

Key Points

Positve
  • Cellebrite DI Ltd (CLBT) achieved notable ARR growth, surpassing $100 million in quarterly revenue for the first time in the company's history.
  • The company delivered a strong third-quarter performance, exceeding expectations with outstanding profitability.
  • Cellebrite DI Ltd (CLBT) has launched Cellebrite Federal Solutions to expand its relationship with the US federal government, which is now fully operational.
  • The company's AI-driven C2C platform is gaining traction, enabling customers to close more cases faster by enhancing productivity and efficiency.
  • Cellebrite DI Ltd (CLBT) has consistently delivered a healthy mix of ARR growth and profitability, comfortably exceeding their baseline for Rule of 45 performance.
Negative
  • The contribution from the CyTech acquisition was minimal, adding slightly below $0.5 million to the total revenue.
  • There is a potential challenge in maintaining the high net retention rate as the company continues to expand.
  • The search for a new CEO could create uncertainty, although the company is committed to finding the best leader possible.
  • The company faces the challenge of expanding its sales force to meet the growing demand and opportunity pipeline.
  • Despite strong performance, there is no guarantee that the current growth rates and profitability can be sustained in the long term.
Operator

Welcome to the Cellebrite third Quarter 2024 financial results conference call. (Operator Instructions)

I would now like to turn the call over to your first speaker today, Mr. Andrew Kramer. Mr. Kramer, the floor is yours.

Andrew Kramer
Cellebrite DI Ltd - Vice President, Investor Relations

Thank you, Todd, and welcome, everybody, to Cellebrite's third quarter 2024 financial results call. I'm joined in New York City today by Yossi Carmil, Cellebrite's CEO; Dana Gerner, Cellebrite's CFO; and Tom Hogan, Cellebrite's Executive Chairman.

There's a slide presentation that accompanies our prepared remarks. Please advance the slides in the webcast viewer to follow our commentary. We will call out the slide number we are referring to in our remarks. The call is being recorded, and a replay of the call will be made available on our website shortly after the call along with the transcript of this event soon after.

Starting with slide 2, a copy of today's press release and financial statements, including GAAP to non-GAAP reconciliations, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot